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VISCERAL LEISHMANIASIS IN BRAZIL: REVISITING PARADIGMS OF
EPIDEMIOLOGY AND CONTROL
Filipe DANTAS-TORRES(1,2) & Sinval Pinto BRANDÃO-FILHO(1)
SUMMARY
In the last 20 years, despite the known underestimation of cases, Brazil registered a marked increase in the incidence of
visceral leishmaniasis. The main goal of this review is to reflect on some aspects of this zoonosis in Brazil and also to
encourage the discussion in order to find more viable, effective and affordable strategies to be implemented by the Brazilian
Leishmaniasis Control Program. The current situation of visceral leishmaniasis in Brazil might be seen as a paradox: the
most important aspects of the disease are known, but so far the control of this disease has not yet been achieved. The current
control strategies have not been able to prevent the geographical expansion, and even a rise in the incidence and lethality of
visceral leishmaniasis. There is a need not only for a better definition of priority areas, but also for the implementation of a
fieldwork monitoring system to the disease surveillance that could permit a further evaluation of the control program in
areas where visceral leishmaniasis is endemic.
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INTRODUCTION
Leishmaniases are diseases with significant clinical and
epidemiological diversity, which involves many different species of
Leishmania parasites, phlebotomine sandfly vectors, and reservoir hosts
in both zoonotic and anthroponotic cycles of transmission. There is a
remarkable increase in risk factors for leishmaniases worldwide and
the disease burden is increasing22. Visceral leishmaniasis (VL) is the
most devastating form of leishmaniases, because it is usually fatal if
untreated. It is officially estimated that about 500,000 cases and 59,000
deaths occur every year due to this form of leishmaniases24,48,49. VL
represents a serious problem of public health in both Old and New
World. However, some 90% of cases occur in poor rural and suburban
areas of Bangladesh, India, Nepal, Sudan and Brazil, the latter
responsible for most of cases reported in Latin America34. About 80%
of VL victims have less than US$ 2 a day to live on49.
In developing countries of South America, the control of VL is
clearly more complex than in Mediterranean countries. In developing
countries there are a number of ecological, epidemiological, and socio-
economic factors that may reduce the impact of the control programs.
In Brazil, for example, about 3,500 cases of VL are notified every year
and, generally, they are associated with both poor living conditions
and infant malnutrition9,40,42. On the other hand, in developed countries
the situation is at least different. In Mediterranean countries (e.g. Spain),
the culling of seropositive dogs and insecticide house spraying are not
used as usual control measures21. Annually, thousands of people get
infected with L. infantum (synonymous L. chagasi33) in these countries,
but, unexpectedly, only a few of them get sick or die due to VL.
Additionally, the cases are usually associated to other health conditions,
such as HIV infection. How can these different patterns of the disease
be explained? Obviously, the comparison between so different countries,
like Brazil and Spain, is difficult, because many other aspects such as
people’s behaviors, level of education and socio-economic conditions
must be considered.
For quite some time, the etiologic agent of VL, its molecular
biology, and antimicrobial susceptibility have been studied. A number
of advances have also been obtained on taxonomy, genetics, molecular
biology and behavior of Lutzomyia longipalpis, the main vector of L.
infantum in Brazil. The host immune response and its implications for
diagnosis, treatment, and prevention of VL have also been investigated.
Many aspects of the disease ecoepidemiology were discovered in the
last 20 years, and this has been used for the development of new control
measures. However, a marked increase in the incidence of VL was
observed in the last two decades. From 1980 to 2003, a total of 51,222
cases were officially notified in Brazil11.
As observed with other communicable diseases (e.g.
tuberculosis), the most important features of VL are well understood,
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but the current control strategies are not sufficient to control the
disease. How this paradox can be explained? In this context, we
reflect here on some aspects of VL in Brazil, aiming to contribute
to the discussion in order to find more effective and feasible control
measures to be implemented in the Brazilian Leishmaniasis Control
Program (BLCP).
The dog and other possible domestic source of infection
In Brazil, the domestic dog Canis familiaris has long been
incriminated as the main reservoir of L. infantum infection. It is because
the high susceptibility to infection and high skin parasitism frequently
observed in this host and mainly due to its close relationship with
man6, in both rural and urban areas. Hence, the presence of seropositive
dogs in human dwellings is seen as a possible risk factor for L. infantum
infection17.
From 1980 to 1991, a total of 137,243 dogs (both seropositive and
stray dogs) were killed during the activities undertaken by the BLCP29.
In the same period, several outbreaks of VL occurred in both rural and
urban areas. The disease has expanded its area of occurrence, and now
it is endemic in at least 19 Brazilian states. In the same way, the
incidence rate of VL continues to increase and the lethality is still
around 10%4,40,42. What is going on? Are domestic dogs the sole source
of infection in all foci of VL in Brazil? Can asymptomatic infected
people also be acting as reservoir hosts in urban areas? Can the culling
of seropositive dogs reduce the incidence rate of VL in humans? Many
plausible explanations could be providing on these questions but, in
fact, this is a complex issue and the opinions may vary widely.
Indeed, domestic dogs are the main domestic reservoirs of L.
infantum infection in the transmission cycle of zoonotic visceral
leishmaniasis (ZVL)16,20. But, can other domestic or synanthropic
animals play any role as reservoirs of infection? Recently, a domestic
cat Felis catus was found naturally infected with L. infantum in an
area of transmission of VL in São Paulo State43. However, the
epidemiological role of the cat is still unclear.
In 2002, the role of the domestic chicken Gallus gallus in the
epidemiology of urban VL in Brazil was discussed1. There are some
factors precluding the chicken as a Leishmania host, impeding this
species as a reservoir51. It is known that Leishmania infection is
unable to develop in some birds and also that existing infections in
the phlebotomine sandfly might be eliminated when it ingests a
second blood meal from chickens. On the other hand, chickens are
very attractive to phlebotomine sandflies and also to reservoir hosts
of L. infantum infection, such as the crab-eating fox Cerdocyon
thous. Consequently, the chickens might favor the link between the
sylvatic and domestic transmission cycles. Thus, in some regions,
the domestic chickens must be seen as a risk factor for the presence
of vectors and reservoir hosts of L. infantum next to human
habitations.
L. infantum/HIV co-infection is a relatively new major challenge
for public health in many countries2,36, including Brazil4. It has been
proven that L. infantum/HIV co-infected patients might be highly
infectious to phlebotomine sandflies35. In Spain, the incidence of co-
infection is high, and some 68% of the L. infantum/HIV patients are
intravenous-drug users. Hence, there has also been speculation of
human-human transmission by means of shared needles2. Occasionally,
Leishmania parasites may also be transmitted by blood transfusion31,39.
It is usually believed that infected people are only incidental hosts of
L. infantum infection, but there is evidence indicating that infected
people might also act as reservoir of infection for phlebotomine
sandflies. In fact, a recent study demonstrated that Brazilian subjects
with active VL might act as source of L. infantum infection to colonized
Lu. longipalpis15.
Sylvatic reservoir hosts
The crab-eating fox have been incriminated as the primary reservoir
host of L. infantum infection in Brazil and Venezuela20,30. In general,
the infection rates in canids other than the domestic dog is low, but
sometimes might be high, as observed in South American foxes.
However, wild canids do not live either near or in human habitation
and, hence, they have a secondary importance in the epidemiology of
ZVL.
The opossum Didelphis albiventris was found naturally infected
by L. infantum in Brazil44,45, as well as D. marsupialis in Colombia13,47
and Venezuela52. In Barra de Guaratiba, Rio de Janeiro State, the
distance of the house from the forest border, its altitude and the presence
of D. marsupialis in the backyard were found to be predictor factors
for L. infantum infection in dogs11. There are some records of natural
infection in both domestic and wild rodents. In Italy, the common
domestic rat Rattus rattus is strongly suspected as a secondary reservoir
of L. infantum48 and there is a record of L. chagasi infection in this
same rodent in Venezuela52. Records of natural infection were also
verified in the spiny rat Proechimys canicollis in Colombia13. Using a
PCR technique, we have recently detected the presence of L. infantum
DNA fragment in an exemplar of water rat Nectomys squamipes and in
an opossum D. albiventris, both trapped in an Atlantic rain forest area
of Pernambuco State (unpublished data). These findings are evidences
that other sylvatic mammals might be involved in the maintenance of
the L. infantum enzootic cycle, acting as primary reservoir hosts of
this parasite.
In fact, some non-domestic mammals (e.g., R. rattus and D.
albiventris) that were already found naturally infected with L. infantum
are considered to be synanthropic animals (i.e., non-domestic animals
that habitually share and profit from the human ecotope). This process
of domiciliation is important for the establishment of new
epidemiological patterns of VL, particularly in the urban cycle of
transmission.
The Brazilian Leishmaniasis Control Program (BLCP)
Although the BLCP has spent an important amount of initiatives
to surveillance and control of VL, the current disease burden indicates
that more and more efforts are still need. The World Health Organization
(WHO) is working in the establishment of public-private partnerships
to attract more resources for both research and control of
leishmaniasis23, but most of the current research effort and resources
should priorize areas where the disease burden is greatest19.
The BLCP is based on three main control measures: diagnosis and
DANTAS-TORRES, F. & BRANDÃO-FILHO, S.P. - Visceral leishmaniasis in Brazil: revisiting paradigms of epidemiology and control. Rev. Inst. Med. trop. S. Paulo, 48(3):151-156, 2006.
153
early treatment of human cases, immunological screening and culling
of seropositive dogs and insecticide spraying against phlebotomine
sandflies. These control strategies have remained unchanged since the
1950’s20, and have not been able to reduce the incidence of human
cases to an acceptable level8,14. Indeed, the prevalence of VL has been
increased and the disease has become a serious public health problem
in several Brazilian states.
In the past few years, it has been suggested that there is a need for
a closer approximation between researchers and public health workers
in order to revise the current control strategies and to define procedures
capable of accurately assessing their impact14,29. Many initiatives have
been developed, including the implementation of reference services
by the Health Surveillance Secretary of the Ministry of Health.
Recently, the activities of the BLCP were decentralized and now they
are under responsibility of the municipalities. However, after this
decentralization, the performance of local teams should be monitored
by the central level, which needs not only to evaluate, but also to support
the developed activities. This is important for the improvement of the
BLCP and thereby its impact would be better evaluated.
Culling of seropositive dogs: a limited impact
In the past, experts in the field of leishmaniasis6 recognized that
there is no well-established control strategy for canine leishmaniasis
and until now the efficacy of dog culling remains highly
questionable23. The true number of dogs that need to be killed in
order to decrease the incidence of VL in man is unknown. Moreover,
the selective elimination of seropositive dogs is expensive and difficult
to implement6,23, and it risks antagonizing people against the
authorities responsible6.
There are several points to be considered on the culling of
seropositive dogs: the limitation of the immunological screenings to
detect anti-Leishmania antibodies, either with indirect immuno-
fluorescence assay3 or enzyme-linked immunosorbent assay16, the
opposition of dog owners to the culling of asymptomatic dogs, and the
lack of evidence that this method is effective to reduce the incidence
rate of VL in all areas where it has been used14. It has been demonstrated
that the culling of seropositive dogs has a limited impact on the
reduction of human incidence5,25,34. Mathematical models have also
shown the limitations of this strategy16, which may be less effective
than others26.
A recent study showed that dog-culling programs do not reduce
the incidence of canine Leishmania infection40. From 1997 to 2000 a
cohort of dogs in an urban area in Brazil was followed up and the
authors observed that several dogs immigrated to the study area
throughout the study period. These new dogs replaced most of the
eliminated ones. Most important, it was the fact that 15% of the new
dogs had already Leishmania infection. This study not only pointed
down the effectiveness of dog-culling programs, but also showed that
new strategies for VL control are need.
Phlebotomine sandfly control
The DDT was the first insecticide used against phlebotomine
sandflies in Brazil. During the 1950’s, the late “Departamento Nacional
de Endemias Rurais (DENERu)” used this insecticide against these
vectors in many foci of the disease20. Despite of the side effects on
both human health and environment, the DDT is still used today34,
though other insecticides have been used, such as pyrethroids (e.g.
deltamethrin)9,38.
Other alternatives have been proposed for the control of
phlebotomine sandflies. Insecticide-impregnated dog collars, for
example, can protect dogs from the bites of the vectors for several
weeks18,27,32,41. The community-wide application of deltamethrin-
impregnated dog collars had already showed efficacy not only to
protect dogs from L. infantum infection, but also in reducing the risk
of infection in Iranian children27. This is a good strategy that should
be used in areas of high transmission, based on knowledge of vector’s
seasonality, and also in dogs from non-enzootic areas during trips to
enzootic areas.
In general, it is said that the vector control is one of the most
important measures in the control of vector-borne diseases. But there
is a consensus that the control of phlebotomine sandflies is not an easy
task. Their breeding sites, are difficult to find, which limits the
development of control measures focused on immature forms of these
vectors. In Brazil, it is known that Lu. longipalpis populations are
widely spread in both rural and urban areas. However, there is a lack
of field studies demonstrating the degree of endo/exophily and endo/
exophagy of Lu. longipalpis in several foci of the disease. Undoubtedly,
before choosing the vector control strategy, it is important to further
know these aspects of the phlebotomine sandfly behavior24.
Canine vaccination: a current discussion
An efficient antileishmanial vaccine for dogs would be an alternative
to prevent leishmaniasis in dogs. Currently, there has been discussion
on a new vaccine against canine visceral leishmaniasis (Leishmune -
Fort Dodge Animal Health) that was recently registered by the Brazilian
Ministry of Agriculture, Livestock and Food Supply. However, this
new possibility was the aim of much debate and was not recommended
by the Ministry of Health11. This position has been justified by the
lack of field studies showing the impact of dog vaccination on the
incidence of VL in humans and the cost-effectiveness of this measure.
A multidisciplinary group of researchers have long been studying
the FML-vaccine7,46. A field study in a LV-endemic area of Rio Grande
do Norte State showed that this vaccine induced a significant long
lasting and strong protective effect against canine visceral
leishmaniasis7. These studies also demonstrated that almost all
vaccinated dogs presented detectable antibodies against Leishmania
antigens and, at the moment, there is no way to distinguish antibodies
developed due to natural infection from those developed due to
vaccination. Hence, since seropositive dogs are often eliminated during
the activities of the BLCP, the vaccinated dogs could be erroneously
eliminated. New tools capable of identifying antibodies produced
specifically due to vaccination would be the best way to resolve this
limitation.
Several aspects of the mechanisms of antileishmanial immune
responses in canine infection have been clarified by recent studies,
though many aspects remain to be discovered. Anyway, some advances
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on canine Leishmania vaccines have been achieved due to these recent
findings. The antileishmanial vaccine candidates include live or killed
parasites, Leishmania purified fractions, defined recombinant parasite
antigens, live recombinant bacteria expressing Leishmania antigens
and antigen-encoding DNA plasmids28.
Conclusions and perspectives
VL is a focal disease and local epidemiology might differ widely.
Hence, the understanding of details of the reservoir system structure
in each focus is a crucial step to adopt efficient control measures focused
on the reservoirs of infection6. In the last few years, some improvements
have been obtained on the understanding of the structure of these
reservoir systems, but much remains to be discovered.
The restructuration of the diagnosis network should be the first
step to improve the BLCP. The second one is a better basic health
attention on the early treatment of human cases of VL in order to reduce
the lethality of the disease. More resources will be also needed to
study the behavior of phlebotomine sandfly populations, either in areas
where VL is endemic or in those where only sporadic cases have been
reported. Preventive measures directed to reduce the human-vector
contact must be implemented based on the previous knowledge of vector
behavior only. Likewise, the implementation of a fieldwork monitoring
system is justified and would permit a further evaluation, of the
measures recommended by the BLCP.
Both development and implementation of new control measures are
priorities and should be supported by institutions of both public and
private sectors. This is particularly true in the poorest communities at
risk of VL, where the use of either insecticide-impregnated dog collars
or a canine vaccine without financial support will be impracticable.
For decades, researchers have warned that the risk of VL is increasing
in Brazil. In its reports, the Ministry of Health,  showed the process of
urbanization of VL. Consequently, we can say that the current situation
has been predicted. Nowadays, the biggest challenge in control of infectious
diseases, such as VL, is how to translate the knowledge derived from
research into cost-effective, accessible, and affordable control measures.
New approaches, such as rapid diagnostic tools and new affordable/effective
therapeutic options are welcome50. In the same way, it is well known that
to improve the quality of life of the population at risk is a good way to
prevent many infectious and parasitic diseases, which are usually associated
to deficient water supply, malnutrition and poor living conditions. The
development of public policies in order to improve both individual and
community health among the population at risk of VL is crucial and this
perspective is particularly important in Brazil.
The topics discussed in this paper are important for a better
knowledge of the VL epidemiology and should therefore be intended
as a contribution to the BLCP improvement. VL in Brazil is a complex
problem, but a problem that may have solution. How to solve it?
Undoubtedly, to solve it will be possible if, and only if, researchers
and fieldwork programs work together. After all these years of attempts
without success, something has been learned: the solution for the
paradoxical situation of VL in Brazil is seen as an issue of scientific
development and permanent health surveillance, but it is also an issue
of social justice and better quality of life for the population at risk.
RESUMO
Leishmaniose visceral no Brasil: revisitando os paradigmas da
epidemiologia e controle
Nos últimos 20 anos, apesar da conhecida subestimação de casos,
o Brasil registrou um marcado aumento na incidência da leishmaniose
visceral. O principal objetivo desta revisão é refletir sobre alguns
aspectos desta zoonose no Brasil e também encorajar a discussão a
fim de encontrar novas estratégias, mais viáveis e efetivas, para serem
implementadas no Programa Brasileiro de Controle das Leishmanioses.
A situação atual da leishmaniose visceral no Brasil pode ser vista como
um paradoxo: os aspectos mais importantes da doença são conhecidos,
mas o controle desta doença ainda não foi conseguido. As estratégias
de controle atuais não têm sido capazes de prevenir a expansão
geográfica, além do aumento da incidência e da letalidade da
leishmaniose visceral. Existe a necessidade de uma melhor definição
das áreas prioritárias, mas também da implementação de um sistema
de monitoramento das atividades dirigidas para o controle e vigilância
epidemiológica, o que poderia permitir melhor avaliação do programa
de controle nas diversas regiões do Brasil.
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